1 / 28

Non occupational HIV Exposure prophylaxis

Non occupational HIV Exposure prophylaxis. Chief ’ s conference 2/6/14. Case 1.

elvina
Download Presentation

Non occupational HIV Exposure prophylaxis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Non occupational HIV Exposure prophylaxis Chief’s conference 2/6/14

  2. Case 1 • 32 y/o healthy male p/w possible HIV exposure. Had receptive anal intercourse with new partner 2 days prior and condom broke. Does not know HIV status of partner and was a one night stand ( so partner will not agree to come in for testing). Patient’s last HIV test neg a month ago. STI screen neg also • Now what next?

  3. How does Pep work? • Infection does not occur instantly after an exposure to HIV • The virus needs to spread throughout the body • This may take up to 3 days after the exposure • The “window of opportunity” for PEP • The brief period of time - after an exposure - where HIV has not yet spread throughout the body • During this time, PEP may be able to stop HIV from causing an infection

  4. Post exposure prophylaxis (PEP)- steps involved • Assessment • Counseling • Prescription • Follow-up

  5. Assessment of the risk of HIV transmission A. The nature of the exposure

  6. B. The risk that the source is HIV positive, if their status is unknown • Source Person is Unavailable or Unwilling to Undergo HIV Testing : • initiate PEP and complete 28 day treatment • Source Person is Known to Be HIV-Infected : • information about his/her viral load, ARV hx, h/o ARV drug resistance should be obtained when possible to assist in the selection of an nPEP regimen; however, administration of the first dose of nPEP should not be delayed while awaiting this information • Source Person’s HIV Status Is Unknown and Source Is Available for Testing • obtain the most expeditious HIV test available (ideally with a turnaround time <1 hour), If the test results are not immediately available, the initiation of nPEP should not be delayed pending the test result. • If the source person’s HIV screening test result is neg : nPEP should be continued until results of the plasma HIV RNA assay are available: if the result is positive, the 28-day regimen should be completed; if the result is negative, PEP should be discontinued.

  7. C. Information about the exposed person • most recent HIV test and result • potential exposures within the last 3 months (and earlier as indicated) • previous post-exposure prophylaxis and history of this treatment • evaluation of current STIs; hepatitis B and C infection • pregnancy risk, contraception and lactation, consider emergency contraception • medical history, all medications and drug allergies • psychiatric history • drug and alcohol history • Their knowledge of the source (if unavailable for interview) ***Provision of PEP should not be delayed whilst obtaining this information.

  8. Post exposure prophylaxis (PEP)- steps involved • Assessment • Counseling • Prescription • Follow-up

  9. Discuss the following issues with the patient and should document that they were discussed before initiating a regimen • Potential benefit, unproven efficacy, and potential toxicity of PEP • Duration of PEP regimen • Importance of adherence to the treatment regimen to prevent PEP failure or the development of drug resistance should infection occur • Need to reduce risk and prevent exposure to others • Clinical and laboratory monitoring and follow-up schedule • Signs and symptoms of acute HIV infection • How a full supply of medication will be obtained • Assess for emotional, psychological, and social factors that can contribute to risk behavior, such as depression, history of sexual abuse, and drug and alcohol use. • Refer patients to mental health and/or substance use programs when indicated and should consider the need for intensive risk-reduction counseling services

  10. Post exposure prophylaxis (PEP)- steps involved • Assessment • Counseling • Prescription • Follow-up

  11. Initiate ideally within 2 hrs, & up to 72hrs • Decisions regarding initiation beyond 36 hours should be made by the clinician in conjunction with the patient with the realization of diminished efficacy when timing of initiation is prolonged • No PEP if exposure >72hrs • Starter packs with a 3- to 5-day supply of medication should be available on-site for rapid initiation of treatment, and arrangements should be made for continuation of treatment. • Unlike protease inhibitors, which block HIV replication in steps after integration with cellular DNA, all three drugs in the recommended regimen act before viral integration with cellular DNA, providing a theoretical advantage in preventing establishment of HIV infection

  12. Post exposure prophylaxis (PEP)- steps involved • Assessment • Counseling • Prescription • Follow-up

  13. Case 2 • 24y/o healthy male presents for his annual physical. He reports he his in a monogamous relationship with another male. However, his partner was diagnosed of HIV a year ago and is currently on HAART. He inquires about prophylaxis for HIV • What next?

  14. What is PrEP to prevent HIV infection? • The ongoing use of one or two antiretrovirals by HIV-negative individuals starting before an exposure and continuing afterwards • A potential option to prevent infection from ongoing exposures to HIV during periods of risk • A recently proven strategy still being studied

  15. What’s involved in taking PrEP? • Assessment • Counseling • Prescription • Follow-up

  16. Men who have sex with men (MSM) • Individuals who are in a sero discordant sexual relationship with a known HIV infected partner • Male to female and female to male transgender individuals engaging in high risk sexual behaviors • Individuals engaging in transactional sex • Injection drug users who share needles • Individuals who have been prescribed non occupational post exposure prophylaxis who demonstrate continued high risk behavior or have used multiple courses of nPEP

  17. PEPline • The National Clinicians' Post-Exposure Prophylaxis Hotline • 1-888-448-4911 • 24 hours a day; 7 days a week • PEP Guidelines: http://www.nccc.ucsf.edu/hiv_clinical_resources/pep_guidelines/

  18. References • http://www.hivguidelines.org/wp-content/uploads/2013/09/hiv-prophylaxis-following-non-occupational-exposure.pdf • http://www.cdc.gov/hiv/prevention/research/index.html?s_cid=tw_c-nchhstp-nhtd-036 • http://www.ashm.org.au/default2.asp?active_page_id=251

  19. Thank you for not having questions

More Related